Connect with us

Healthcare

Trump COVID-19 adviser Scott Atlas urges Michigan to ‘rise up’ against Whitmer’s new restrictions

Published

on

scott atlas

White House coronavirus task force member, Dr. Scott Atlas, urged the people of Michigan to “rise up” after Gov. Gretchen Whitmer announced new coronavirus restrictions, in a tweet posted Sunday.

“The only way this stops is if people rise up,” Atlas tweeted. “You get what you accept. #FreedomMatters #StepUp”

https://twitter.com/SWAtlasHoover/status/1328120887128842240

Atlas followed up with a tweet to clarify he does not condone violence, “Hey. I NEVER was talking at all about violence. People vote, people peacefully protest. NEVER would I endorse or incite violence. NEVER!!”

https://twitter.com/SWAtlasHoover/status/1328171502211043328

Gov. Whitmer announced in a news conference Sunday that Michigan will begin a “three-week pause targeting indoor social gatherings and other group activities.”

The new restrictions will temporarily halt in-person instruction at high schools and colleges, indoor dine-in service at restaurants and bars and high school athletics as well as close some businesses, including movie theaters, bowling alleys and casinos.

Whitmer urged the public to “double down” with precautions such as wearing a mask and keeping distance to avoid a second stay-at-home order.

Last month, Atlas received backlash after he had suggested that masks do not work to stop the spread of the coronavirus. He tweeted “Masks work? NO,” which has since been removed by Twitter.

“I don’t understand why the tweets were deleted,” Atlas said in an email, calling out Twitter’s censorship.

He said his tweet was intended to show that “general population masks and mask mandates do not work,” and he clarified that the correct policy is to use masks when one cannot socially distance.

Atlas added that infections exploded even with mandates in Los Angeles County, Miami-Dade County, Hawaii, Alabama, the Philippines, Japan and other places.

You may like

Continue Reading

China

FDA will work with China to import cancer drugs due to U.S. shortages

Published

on

FinalFDAshutterstock 1044596995

Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.

Foreign Desk News writes:

Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.

“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.

Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.

“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.

Foreign Desk News adds:

The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.

 

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending